First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with EGFR mutation as the initial and solitary site of postoperative recurrence

Leptomeningeal metastasis (LM) from lung cancer has poor prognosis, and effective therapy has not been established. We present the case of a 54-year-old man with LM from lung adenocarcinoma harboring EGFR L858R point mutation, who received osimertinib as first-line therapy. He had previously undergo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int Cancer Conf J
Main Authors: Ono, Yuki, Takada, Kazuki, Osoegawa, Atsushi, Kinoshita, Fumihiko, Oba, Taro, Tsukamoto, Shuichi, Tagawa, Tetsuzo, Oda, Yoshinao, Mori, Masaki
Formato: Artigo
Idioma:Inglês
Publicado: Springer Singapore 2020
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797384/
https://ncbi.nlm.nih.gov/pubmed/33489707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00453-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares